Cardiac structure and function after revascularization versus medical therapy for renal artery stenosis: the ASTRAL heart echocardiographic sub-study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cardiac structure and function after revascularization versus medical therapy for renal artery stenosis: the ASTRAL heart echocardiographic sub-study

Published:2019-06-14 Issue:1 Volume:20 Page:
ISSN:1471-2369
Container-title:BMC Nephrology
language:en
Short-container-title:BMC Nephrol

Author:

Green Darren,Vassallo Diana,Handley Kelly,Ives Natalie,Wheatley Keith,Chrysochou Constantina,Hegarty Janet,Wright Julian,Moss Jon,Patel Rajan K.,Deighan Chris,Webster John,Rowe Peter,Carr Sue,Cross Jenny,O’Driscoll Jamie,Sharma Raj,Mark Patrick,Kalra Philip A.

Funder

Medtronic

Kidney Research UK

Medical research council UK

Publisher

Springer Science and Business Media LLC

Subject

Nephrology

Link

http://link.springer.com/content/pdf/10.1186/s12882-019-1406-y.pdf

Reference32 articles.

1. Kalra PA, Guo H, Kausz AT, et al. Atherosclerotic renovascular disease in United States patients aged 67 years or older: risk factors, revascularization, and prognosis. Kidney Int. 2005;68(1):293–301. https://doi.org/10.1111/j.1523-1755.2005.00406.x .

2. de Silva R, Loh H, Rigby AS, et al. Epidemiology, associated factors, and prognostic outcomes of renal artery stenosis in chronic heart failure assessed by magnetic resonance angiography. Am J Cardiol. 2007;100(2):273–9. https://doi.org/10.1016/j.amjcard.2007.02.098 .

3. Wright JR, Shurrab AE, Cooper A, Kalra PR, Foley RN, Kalra PA. Left ventricular morphology and function in patients with atherosclerotic Renovascular disease. J Am Soc Nephrol. 2005;16(9):2746–53. https://doi.org/10.1681/asn.2005010043 .

4. Zeller T, Rastan A, Schwarzwalder U, et al. Regression of left ventricular hypertrophy following stenting of renal artery stenosis. J Endovasc Ther. 2007;14(2):189–97 doi:1526-6028-14-2-189 [pii]\r10.1583/1545-1550(2007)14[189,ROLVHF]2.0.CO;2.

5. Wheatley K, Ives N, Gray R, et al. Revascularization versus medical therapy for renal-artery stenosis. N Engl J Med. 2009;361(20):1953–62.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kidney Intrinsic Mechanisms as Novel Targets in Renovascular Hypertension;Hypertension;2024-02

2. Atherosclerotic renovascular disease: a clinical practice document by the European Renal Best Practice (ERBP) board of the European Renal Association (ERA) and the Working Group Hypertension and the Kidney of the European Society of Hypertension (ESH);Nephrology Dialysis Transplantation;2023-05-18

3. Relationship Between Gene Polymorphism of Methylenetetrahydrofolate Reductase C677T and Left Ventricular Hypertrophy in Chinese Patients with Chronic Kidney Disease;Laboratory Medicine;2021-03-08

4. Left ventricular mass reduction and hypertrophy regression following renal artery revascularization: a meta-analysis;Journal of Hypertension;2020-08-21

5. CORRELATION OF SERUM CD147 AND PCIII EXPRESSION LEVELS WITH THE PROGRESSION OF HYPERTENSIVE LEFT VENTRICULAR HYPERTROPHY;ACTA MEDICA MEDITERR;2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3